TMDX vs TPR · P/E 17, rev $363.9M vs P/E 46, rev $8.00B
TransMedics Group Inc (TMDX) versus Tapestry Inc (TPR) — a side-by-side from cached financials, not a winner call.
TransMedics Group Inc (TMDX) is a medical devices company listed on NASDAQ.
Tapestry Inc (TPR) is a luxury goods company listed on NYSE.
Latest reported TMDX revenue for 2026-06-30 was $363.9M. Net income was $22.0M. TMDX currently screens at market cap $2.53B and trailing P/E 16.8.
Latest reported TPR revenue for 2026-06-27 was $8.00B. Net income was $1.53B. Revenue was up 14.2% from 2025-06-28 to 2026-06-27. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
TMDX currently screens at market cap $2.53B and trailing P/E 16.8. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
Not investment advice. Open the TMDX and TPR stock pages for the full models.
Not investment advice.